CBLL
NASDAQ
$18.43
Ceribell Inc (CBLL)
CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company is headquartered in Sunnyvale, California.
Sector:
Healthcare
Industry:
Medical Devices
Buy
Target: $26.86 (+45.74%)
Market Cap
$734M
Free Cash Flow Yield
-6.73%
Beta (5Y)
1.51
Price Chart
Valuation
Market Cap$734M
P/S7.74
P/B5.16
Profitability
Total Revenue (TTM)$95M
Gross Profit (TTM)$83M
EBITDA-$64M
Profit Margin-74.5%
Operating Margin-78.3%
EPS-$1.62
Financial Health
Free Cash Flow Yield-6.73%
Growth & Risk
Beta (5Y)1.51
Sharpe Ratio0.51